IRMD — iRadimed Corporation stock price and chart

IRMD

$88.24+0.67%

as of close, Oct 20, 2026

☾ AH $88.24 +0.67%

iRadimed CorporationStock · HealthcareRussell 2000 · 0.02% of IWMRussell 3000 · 0.001% of IWVUS Stock Market · 0.001% of VTI

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEEE

20162019202120242026

10.020.030.040.050.060.070.080.090.0100.001.0M$88.24

2026-10-20

Price$88.24

MA20$89.78

MA50$89.07

Vol321.6K

What would $1,000 invested in IRMD be worth today? →

IRMD returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $88.24
YTD price return: -9.29%
YTD total return: -8.70%
Next earnings: Nov 2, 2026
Market cap: 1.1B2016-12 118.9M2026-10 1.1B+848.9% over the window
Enterprise value: 1.1B
Shares outstanding: 12.8M2016-06 10.7M2026-06 12.8M+19.8% over the window
52W low: $73.25
52W high: $107.90
From 52W high: -18.22%
From 52W low: +20.47%
52W range: 43%

Volume

Rel volume: 0.66×
30D volume: 125.3K
30D $ vol: 10.7M

Fundamentals

Sales (ttm): 86.3M2016-06 35.8M2026-06 86.3M+141.0% over the window
Sales/share: $6.752016-06 $3.362026-06 $6.75+101.1% over the window
EPS (ttm): $1.792016-06 $0.702026-06 $1.79+154.9% over the window
FCF (ttm): 25.1M2016-06 8.1M2026-06 25.1M+211.2% over the window
FCF/share: $1.962016-06 $0.762026-06 $1.96+159.8% over the window
Book value/share: $7.962016-06 $2.672026-06 $7.96+198.3% over the window
Net margin: 26.70%2016-06 24.5%2026-06 26.7%+8.9% over the window
ROE: 22.66%2016-06 30.9%2026-06 22.7%-26.6% over the window
ROA: 20.05%2016-06 27.2%2026-06 20.1%-26.2% over the window
Current ratio: 9.462016-06 10.252026-06 9.46-7.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +11.22%2025-06-30 → 2026-06-3077.6M → 86.3M (+11.2% total)+12.97%2023-06-30 → 2026-06-3059.9M → 86.3M (+44.2% total)+19.60%2021-06-30 → 2026-06-3035.3M → 86.3M (+144.7% total)+9.20%2016-06-30 → 2026-06-3035.8M → 86.3M (+141.0% total)
Net income: +11.61%2025-06-30 → 2026-06-3020.7M → 23.1M (+11.6% total)+16.22%2023-06-30 → 2026-06-3014.7M → 23.1M (+57.0% total)+38.23%2021-06-30 → 2026-06-304.6M → 23.1M (+404.6% total)+10.13%2016-06-30 → 2026-06-308.8M → 23.1M (+162.4% total)
FCF: +76.85%2025-06-30 → 2026-06-3014.2M → 25.1M (+76.8% total)+45.90%2023-06-30 → 2026-06-308.1M → 25.1M (+210.7% total)+25.84%2021-06-30 → 2026-06-308M → 25.1M (+215.5% total)+12.03%2016-06-30 → 2026-06-308.1M → 25.1M (+211.2% total)
Shares: +0.53%2025-06-30 → 2026-06-3012.7M → 12.8M (+0.5% total)+0.49%2023-06-30 → 2026-06-3012.6M → 12.8M (+1.5% total)+0.75%2021-06-30 → 2026-06-3012.3M → 12.8M (+3.8% total)+1.82%2016-06-30 → 2026-06-3010.7M → 12.8M (+19.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +11.17%2025-06-30 → 2026-06-30$1.61 → $1.79 (+11.2% total)+15.60%2023-06-30 → 2026-06-30$1.16 → $1.79 (+54.5% total)+37.47%2021-06-30 → 2026-06-30$0.36 → $1.79 (+390.8% total)+9.81%2016-06-30 → 2026-06-30$0.70 → $1.79 (+154.9% total)
Sales/share: +10.64%2025-06-30 → 2026-06-30$6.10 → $6.75 (+10.6% total)+12.43%2023-06-30 → 2026-06-30$4.75 → $6.75 (+42.1% total)+18.71%2021-06-30 → 2026-06-30$2.86 → $6.75 (+135.8% total)+7.24%2016-06-30 → 2026-06-30$3.36 → $6.75 (+101.1% total)
FCF/share: +75.93%2025-06-30 → 2026-06-30$1.12 → $1.96 (+75.9% total)+45.20%2023-06-30 → 2026-06-30$0.64 → $1.96 (+206.2% total)+24.90%2021-06-30 → 2026-06-30$0.65 → $1.96 (+203.9% total)+10.02%2016-06-30 → 2026-06-30$0.76 → $1.96 (+159.8% total)
Book value/share: +7.34%2025-06-30 → 2026-06-30$7.41 → $7.96 (+7.3% total)+13.27%2023-06-30 → 2026-06-30$5.47 → $7.96 (+45.3% total)+8.60%2021-06-30 → 2026-06-30$5.27 → $7.96 (+51.0% total)+11.55%2016-06-30 → 2026-06-30$2.67 → $7.96 (+198.3% total)
Dividend/share: +93.91%2025-06-30 → 2026-06-30$0.64 → $1.24 (+93.8% total)+5.67%2023-06-30 → 2026-06-30$1.05 → $1.24 (+18.0% total)n/an/a
Price: +18.16%2025-10-20 → 2026-10-20$74.69 → $88.24 (+18.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+31.38%2023-10-20 → 2026-10-20$38.90 → $88.24 (+126.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.28%2021-10-20 → 2026-10-20$36.55 → $88.24 (+141.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+24.42%2016-10-19 → 2026-10-20$9.92 → $88.24 (+789.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +19.79%2025-10-20 → 2026-10-20$73.67 → $88.24 (+19.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+33.41%2023-10-20 → 2026-10-20$37.15 → $88.24 (+137.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+21.60%2021-10-20 → 2026-10-20$33.19 → $88.24 (+165.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+25.63%2016-10-19 → 2026-10-20$9.01 → $88.24 (+879.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 49.3×2016-12 14.022026-10 48.94+249.0% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 40.9×2016-12 9.312026-10 40.95+339.7% over the window
Fwd P/E: 35.9×
P/S (ttm)Market cap ÷ TTM revenue.: 13.1×2016-12 3.372026-10 13.07+288.0% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 11.1×2016-12 3.882026-10 11.09+185.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 44.9×2016-12 13.072026-10 44.92+243.7% over the window
EV/EBITDA (fy): 36.6×
EV/Sales (ttm): 12.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 2.23%2016-09 7.7%2026-06 2.1%-73.1% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 0.91%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 0.87%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $0.80
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 12.8M ÷ 12.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.53%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.53%) + dividends paid over that year ($15.8M) ÷ market_cap_at(2025-06-30) ($760.5M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 1.55%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 8.4%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $15.8M) ÷ today's market cap ($1.1B). Same caveat as the cash buyback yield.: 1.40%2016-09 8.4%2026-06 1.3%-84.5% over the window

Vs own 10Y history

P/E: 62nd
P/OI: 60th
P/S: 89th
P/B: 93rd
P/FCF: 49th

Bar = where today’s multiple sits in IRMD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+0.67%

-1.57%

+7.45%

-9.06%

YTD

-9.29%

+18.14%

+141.42%

Financial statements

Open full IRMD financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

IRMD — iRadimed Corporation price, chart and key statistics